Coronavirus: once a vaccine is developed, making it in bulk will be the next challenge – The National

Coronavirus: once a vaccine is developed, making it in bulk will be the next challenge – The National

Coronavirus: a vaccine needs to be developed fast and made available to the world. As the race to develop a vaccine for Covid-19 hots up, the EU - in co-operation with France, Germany, the UK, Norway and Saudi Arabia - has launched a massive fund-raising marathon.. And the EU is thinking big money, as always, no less than €7.4 billion in initial funding.. Pharma players capable of producing the right scale of doses are rare.. But even more than the question of when and by whom a vaccine will be discovered - and the German minister of health recently stated this would not happen soon - the major challenge for humanity is the quantity of doses that can be produced and the accessibility of these doses.. Developing a vaccine also creates a possibility of returning to normal economic activity without the fear of a 'second wave'.. Tackling the challenge to ensure massive production and equitable distribution requires collective action.. But the question of transforming production processes to make them more efficient is also crucial.. Intensifying the process of developing a vaccine is a possible approach, with the aim of minimising the equipment and space used.. If the EU wishes to